Évaluation de l’imatinib dans la prise en charge de la leucémie myéloïde chronique au Gabon À propos de dix-sept cas Volume 26, numéro 2, Avril-Mai- Juin. REVUE MEDICALE DE LIEGE. Cliquer ICI pour déclencher le téléchargement de l’article. COMMENT JE TRAITE LA LEUCEMIE MYELOIDE CHRONIQUE. Résumé La leucémie myéloïde chronique (LMC) est un modèle de cancérogenèse. Son pronostic a été exceptionnellement amélioré grâce.
|Published (Last):||14 April 2014|
|PDF File Size:||10.91 Mb|
|ePub File Size:||3.96 Mb|
|Price:||Free* [*Free Regsitration Required]|
Lucemie J Hematol Blood Transfus. For the remaining half of patients, the causes leading to the molecular relapse deserve to be further analyzed. The Glivec international patient assistance mye,oide A retrospective study of leukemia epidemiology in Northern Tunisia. The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Les inhibiteurs des kinases. As per the Law relating to information storage and personal integrity, you have the right to oppose art 26 of that lawaccess art 34 of that law and rectify art 36 of that law your personal data.
Imatinib mesylate therapy in patients of chronic myeloid leukemia with Philadelphia chromosome positive: You can move leucfmie window by clicking on the headline. Top of the page – Article Outline. East Afr Med J.
New strategies to eradicate these residual cells by targeting the hematopoietic niche or directly the leukemic stem cells are being developed. Chronic myeloid leukaemia in central Africans.
Clinical and pronognostic features of Nigerians with chronic myeloid leukemia. Finally, the immune system undoubtedly plays a crucial function in the control of residual leukemic cells; this role should be specified in the future.
Contact Help Who lehcemie we? Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries.
Hematologic and cytogenetic response to Imatinib mesylate in chronic myelogenous leukemia. Acellular oncogene is translocated chroonique the Philadelphia chromosome in chronic myelocytic leukemia. Molecular biology of bcr-abl1-positive CML. Personal information regarding our website’s visitors, including their identity, is confidential.
Tyrosine kinase inhibitor TKI therapy imatinib, dasatinib, nilotinib, bosutinib, ponatinib has led to improved overall and disease-free survival of patients. Access to the full text of this article requires a subscription. S Af Med J. New technologies digital PCR, high-throughput sequencing or NGS were developed to improve the performances of existing methods. An experience from eastern India. Outline Masquer le plan.
N Engl J Med. Chronic myeloid leukaemia at the Kenyatta National Hospital, Nairobi.
Leucémie myéloïde chronique (LMC) · Groupe québécois de recherche en LMC-NMP
Access to the PDF text. Access to the text HTML.
Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction. International recommendations facilitate the management of CML and treatment adjustments.
Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
There was a problem providing the content you requested
Journal page Archives Contents list. Clinical trials have validated TKI discontinuation strategies in patients with sustained deep molecular response. Chronic myeloid leukemia advances in biology and new approaches to treatment.
Chronic myeloid leukaemia in South African blacks. If you are a subscriber, please sign in ‘My Account’ at the top right of the screen. Myeeloide persistence of TKI-refractory leukemic stem cells could explain this result. If you chroniquf to subscribe to this journal, see our rates You can purchase this item in Pay Per View: